SELECTIVE SPECIES SPECIFICITY OF TUMOR-NECROSIS-FACTOR FOR TOXICITY IN THE MOUSE

被引:0
|
作者
BROUCKAERT, P [1 ]
LIBERT, C [1 ]
EVERAERDT, B [1 ]
FIERS, W [1 ]
机构
[1] STATE UNIV GHENT,MOLEC BIOL LAB,KL LEDEGANCKSTR 35,B-9000 GENT,BELGIUM
来源
LYMPHOKINE AND CYTOKINE RESEARCH | 1992年 / 11卷 / 04期
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The selective cytotoxic activity of tumor necrosis factor (TNF) on many transformed human or murine cell lines is (almost) not species-specific. There are, however, a limited number of biological assay systems such as gene induction in murine thymoma cells and the murine thymocyte proliferation assay, in which recombinant murine (rm) TNF, but not recombinant human (rh) TNF is active. We have now investigated the possible species specificity of the lethality-inducing properties of TNF in the mouse. When administered alone, only rmTNF, but not rhTNF caused lethality. This difference was not due to a different endotoxin contamination or to a different pharmacokinetic behavior. When a sensitizing agent, galactosamine, was added, the species specificity was abolished. We have shown previously that similar conclusions could be drawn for at least some of the antitumor mechanisms of TNF. We conclude that to mimic the two major phenomena caused by endotoxin administration, viz. lethality and antitumor effect, two distinct signals are needed. In mice, rmTNF can provide both, while rhTNF needs another agent (a sensitizer) to cause systemic toxicity. The results are discussed with respect to recent findings showing that, in the mouse, rhTNF can only bind to the TNF-R55 receptor type, while rmTNF can bind both to the TNF-R55 and TNF-R75 receptor types.
引用
收藏
页码:193 / 196
页数:4
相关论文
共 50 条
  • [21] CACHECTIN OR TUMOR-NECROSIS-FACTOR
    BANYARD, MRC
    AUSTRALIAN VETERINARY PRACTITIONER, 1987, 17 (01): : 41 - 42
  • [22] TUMOR-NECROSIS-FACTOR AND AIDS
    MUNOZ, RA
    MEDICINA CLINICA, 1995, 104 (01): : 29 - 36
  • [23] TUMOR-NECROSIS-FACTOR AND HYPERMETABOLISM
    SEATON, TB
    COOMBE, N
    MITTELMAN, A
    ANNALS OF INTERNAL MEDICINE, 1990, 112 (09) : 715 - 716
  • [24] TUMOR-NECROSIS-FACTOR AND LYMPHOTOXIN
    KIRCHNER, H
    MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1987, 129 (17): : 303 - 305
  • [25] TUMOR-NECROSIS-FACTOR AND AIDS
    KOBAYASHI, N
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1993, 113 (01): : 1 - 18
  • [26] TUMOR-NECROSIS-FACTOR - AN OVERVIEW
    MAURY, CPJ
    ACTA MEDICA SCANDINAVICA, 1986, 220 (05): : 387 - 394
  • [27] IMMUNOMODULATION BY TUMOR-NECROSIS-FACTOR
    HORI, K
    EHRKE, MJ
    MIHICH, E
    MOLECULAR AND CELLULAR NETWORKS FOR CANCER THERAPY, 1989, 857 : 75 - 79
  • [28] ACUTE TOXICITY AND STABILITY STUDIES ON TUMOR-NECROSIS-FACTOR (TNF) IN MICE
    KHAN, A
    JOHER, A
    ARFAN, M
    JIA, F
    PICHYANGKUL, S
    BERENT, S
    HILL, NO
    BOLLON, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 320 - 320
  • [29] TUMOR-NECROSIS-FACTOR INVOLVEMENT IN THE TOXICITY OF TCDD - THE ROLE OF ENDOTOXIN IN THE RESPONSE
    CLARK, GC
    TAYLOR, MJ
    EXPERIMENTAL AND CLINICAL IMMUNOGENETICS, 1994, 11 (2-3) : 136 - 141
  • [30] TOXICITY OF INTRAVESICAL RECOMBINANT HUMAN TUMOR-NECROSIS-FACTOR IN CYNOMOLGUS MONKEYS
    BAHNSON, RR
    BALLOU, BT
    ERNSTOFF, MS
    CRAMER, DV
    SCHWENTKER, FN
    REILAND, JM
    HAKALA, TR
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1990, 9 (04): : 445 - 447